We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$5.91M +$1.23K +343 +0%
SL
2
Siren LLC
Connecticut
$5.56M +$9.29M +2,587,372 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$4.45M
SB
4
Samsara BioCapital
California
$3.84M
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$3.16M
FP
6
Flagship Pioneering
Massachusetts
$2.78M
APM
7
Avidity Partners Management
Texas
$2.29M -$2.19M -610,538 -36%
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.05M -$53.5K -14,904 -2%
DTC
9
Deep Track Capital
Connecticut
$1.78M
OM
10
Opaleye Management
Massachusetts
$1.41M -$756K -210,500 -24%
BOCH
11
Blue Owl Capital Holdings
New York
$1.11M +$629K +175,000 +51%
UOC
12
UBS O'Connor
Illinois
$773K +$292K +81,202 +29%
ECM
13
ExodusPoint Capital Management
New York
$673K +$177K +49,313 +19%
EAM
14
Exome Asset Management
New York
$642K +$501K +139,400 +88%
BlackRock
15
BlackRock
New York
$562K +$8.58K +2,390 +0.9%
OFM
16
Omega Fund Management
Massachusetts
$540K
Geode Capital Management
17
Geode Capital Management
Massachusetts
$440K -$76.9K -21,415 -9%
Marshall Wace
18
Marshall Wace
United Kingdom
$345K
PA
19
Perceptive Advisors
New York
$251K
Renaissance Technologies
20
Renaissance Technologies
New York
$207K -$75.4K -21,000 -18%
PCM
21
Prelude Capital Management
New York
$192K +$175K +48,800 +121%
Walleye Capital
22
Walleye Capital
New York
$186K -$715K -199,162 -70%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$167K +$178K +49,557 +176%
State Street
24
State Street
Massachusetts
$149K
Acadian Asset Management
25
Acadian Asset Management
Massachusetts
$113K +$65.7K +18,288 +53%